Sarepta Therapeutics, Inc. (SRPT) vs Urogen Pharma (URGN)
- Sarepta Therapeutics, Inc. SRPT 17.06 −4.10%
- Urogen Pharma URGN 34.56 −5.60%
Sarepta Therapeutics, Inc. and Urogen Pharma are both Biotechnology companies. Sarepta Therapeutics, Inc. and Urogen Pharma are of similar size ($1.9B and $1.8B). Urogen Pharma grew revenue faster over the last twelve months: 100.3% against −20.4%. Sarepta Therapeutics, Inc. has the higher net margin (−6.93% vs −51.7%) and the lower return on invested capital (−5.64% vs 0.00%). Across the 17 metrics below, Urogen Pharma leads on 9 and Sarepta Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | SRPT | URGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 59.09% | 90.85% | 65.16% |
| Operating margin | (7.26%) | (35.32%) | 0.00% |
| Net margin | (6.93%) | (51.73%) | 0.00% |
| Free cash flow margin | 3.80% | (84.32%) | 0.00% |
| Return on equity | (9.48%) | 86.49% | (56.36%) |
| Return on assets | (3.98%) | (42.33%) | (48.04%) |
| Return on invested capital | (5.64%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack